0000920465-18-000029.txt : 20180820 0000920465-18-000029.hdr.sgml : 20180820 20180820210618 ACCESSION NUMBER: 0000920465-18-000029 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180816 FILED AS OF DATE: 20180820 DATE AS OF CHANGE: 20180820 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Rolke James CENTRAL INDEX KEY: 0001693858 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36282 FILM NUMBER: 181029393 MAIL ADDRESS: STREET 1: 10182 TELESIS COURT, 6TH FLOOR CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LA JOLLA PHARMACEUTICAL CO CENTRAL INDEX KEY: 0000920465 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330361285 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4550 TOWNE CENTRE COURT CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-207-4264 MAIL ADDRESS: STREET 1: 4550 TOWNE CENTRE COURT CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 wf-form4_153481356291910.xml FORM 4 X0306 4 2018-08-16 0 0000920465 LA JOLLA PHARMACEUTICAL CO LJPC 0001693858 Rolke James C/O LA JOLLA PHARMACEUTICAL COMPANY, 4550 TOWNE CENTRE COURT SAN DIEGO CA 92121 0 1 0 0 Chief Scientific Officer Common Stock 2018-08-16 4 P 0 1000 21.997 A 74328 D /s/ Ryan Murr, as attorney-in-fact for James M. Rolke 2018-08-20